Overview

Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

Status:
Recruiting

Trial end date:
2024-05-01

Target enrollment:

Participant gender:

Summary

The investigators propose in this trial to test a hepatic chemotherapy, consisting of the hepatic intra-arterial injection Idarubicin, emulsified with Lipiodol, lipid vector, without embolization in the treatment of non-metastatic, unresectable hepatocellular carcinoma on cirrhosis with Child-Pugh A/B7.

Phase:

Phase 2

Details

Lead Sponsor:

University Hospital, Montpellier

Collaborator:

Guerbet

Treatments:

Ethiodized Oil
Idarubicin